Related references
Note: Only part of the references are listed.Translation of New and Emerging Therapies for Genetic Cardiomyopathies
Adam S. Helms et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2022)
Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression
Anthony M. Gacita et al.
CIRCULATION (2021)
Targeted delivery of therapeutic agents to the heart
Susmita Sahoo et al.
NATURE REVIEWS CARDIOLOGY (2021)
Dose-Dependent Microdystrophin Expression Enhancement in Cardiac Muscle by a Cardiac-Specific Regulatory Element
Alberto Malerba et al.
HUMAN GENE THERAPY (2021)
Muscle-Specific Promoters for Gene Therapy
V. V. Skopenkova et al.
ACTA NATURAE (2021)
Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation
Mohit M. Hulsurkar et al.
CIRCULATION (2021)
Anatomy of the cardiac conduction system
Santosh K. Padala et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2021)
Variability in Cardiac miRNA-122 Level Determines Therapeutic Potential of miRNA-Regulated AAV Vectors
Izabela Kraszewska et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
T-box transcription factor 3 governs a transcriptional program for the function of the mouse atrioventricular conduction system
Rajiv A. Mohan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II
Vassilios J. Bezzerides et al.
CIRCULATION (2019)
TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
Andrea Grund et al.
EMBO MOLECULAR MEDICINE (2019)
A reference map of murine cardiac transcription factor chromatin occupancy identifies dynamic and conserved enhancers
Brynn N. Akerberg et al.
NATURE COMMUNICATIONS (2019)
Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector
Li Ni et al.
CIRCULATION RESEARCH (2019)
A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway
Lorenz H. Lehmann et al.
NATURE MEDICINE (2018)
A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity
Kyle Chamberlain et al.
HUMAN GENE THERAPY (2018)
Eukaryotic core promoters and the functional basis of transcription initiation
Vanja Haberle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Enhancing atrial-specific gene expression using a calsequestrin cis-regulatory module 4 with a sarcolipin promoter
Jimeen Yoo et al.
JOURNAL OF GENE MEDICINE (2018)
Construction and Development of a Cardiac Tissue-Specific and Hypoxia-Inducible Expression Vector
Shahrooz Ghaderi et al.
ADVANCED PHARMACEUTICAL BULLETIN (2018)
TNNTI, TNNT2, and TNNT3: Isoform genes, regulation, and structure-function relationships
Bin Wei et al.
GENE (2016)
Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease
Farah Sheikh et al.
GENE (2015)
Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease
Sang-oh Han et al.
HUMAN GENE THERAPY (2015)
Genome-wide Computational Analysis Reveals Cardiomyocyte-specific Transcriptional Cis-regulatory Motifs That Enable Efficient Cardiac Gene Therapy
Melvin Y. Rincon et al.
MOLECULAR THERAPY (2015)
Optogenetics for in vivo cardiac pacing and resynchronization therapies
Udi Nussinovitch et al.
NATURE BIOTECHNOLOGY (2015)
Gene regulatory elements of the cardiac conduction system
Karel van Duijvenboden et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2014)
Rapid and highly efficient inducible cardiac gene knockout in adultmice using AAV-mediated expression of Cre recombinase
Stanislas Werfel et al.
CARDIOVASCULAR RESEARCH (2014)
A Large Permissive Regulatory Domain Exclusively Controls Tbx3 Expression in the Cardiac Conduction System
Jan Hendrik van Weerd et al.
CIRCULATION RESEARCH (2014)
Increased Sarcolipin Expression and Adrenergic Drive in Humans With Preserved Left Ventricular Ejection Fraction and Chronic Isolated Mitral Regurgitation
Junying Zheng et al.
CIRCULATION-HEART FAILURE (2014)
AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model
Philip W. J. Raake et al.
EUROPEAN HEART JOURNAL (2013)
Generation of Shox2-Cre allele for tissue specific manipulation of genes in the developing heart, palate, and limb
Cheng Sun et al.
GENESIS (2013)
Catecholaminergic Polymorphic Ventricular Tachycardia
Antoine Leenhardt et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)
Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease
Lijun Sun et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution
K-M R. Prasad et al.
GENE THERAPY (2011)
microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors
A. Geisler et al.
GENE THERAPY (2011)
Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease
Chyan-Jang Lee et al.
JOURNAL OF CARDIOLOGY (2011)
Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block
Susan Cheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats
O. J. Mueller et al.
GENE THERAPY (2008)
Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors
Ina Gruh et al.
JOURNAL OF GENE MEDICINE (2008)
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors
P. W. Raake et al.
GENE THERAPY (2008)
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue
Sven T. Pleger et al.
CIRCULATION (2007)
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
Maja Z. Salva et al.
MOLECULAR THERAPY (2007)
Targeting the heart with gene therapy-optimized gene delivery methods
Oliver J. Mueller et al.
CARDIOVASCULAR RESEARCH (2007)
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors
OJ Müller et al.
CARDIOVASCULAR RESEARCH (2006)
Nkx2-5 pathways and congenital heart disease: Loss of ventricular myocyte lineage progressive cardiomyopathy and complete heart block
M Pashmforoush et al.
CELL (2004)
Adeno-associated viral vector delivers card iac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts
H Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Transgenic analysis of the atrialnatriuretic factor (ANF) promoter:: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF
EA Small et al.
DEVELOPMENTAL BIOLOGY (2003)
Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling
S Minamisawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction
R Aikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Vigilant vector: Heart-specific promoter in an adeno-associated virus vector for cardioprotection
MI Phillips et al.
HYPERTENSION (2002)
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors
MA Hauser et al.
MOLECULAR THERAPY (2000)
Share Paper
